NEW YORK, Feb. 20, 2018 -- Pomerantz LLP announces that a class action lawsuit has been filed against Capitala Finance Corporation (“Capitala” or the “Company”) (NASDAQ:CPTA) and certain of its officers. The class action, filed in United States District Court, for the Central District of California, Western Division, and docketed under 18-cv-00052, is on behalf of a class consisting of investors who purchased or otherwise acquired Capitala securities, seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.
If you are a shareholder who purchased Capitala securities between January 4, 2016, and August 7, 2017, both dates inclusive, you have until February 26, 2018, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
[Click here to join this class action]
Capitala Finance Corporation is a business development company that invests primarily in first and second liens, subordinated debt and, to a lesser extent, equity securities issued by lower and traditional middle-market companies.
Capitala Investment Advisors, LLC (“Capitala Investment Advisors”) manages the Company’s investment activities. The Company’s Board of Directors supervises the Company’s investment activities. The Company’s executive officers are part of Capitala Investment Advisors’ management team.
Under the Company’s investment advisory agreement with Capitala Investment Advisors (the “Investment Advisory Agreement”), the Company pays Capitala Investment Advisors an annual base management fee based on the Company’s gross assets as well as an incentive fee based on the Company’s performance.
On January 4, 2016, the Company announced that Capitala Investment Advisors agreed to voluntarily waive its quarterly incentive fee.
The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Capitala Investment Advisors had been losing professional talent in both underwriting and portfolio management due to the waiving of its incentive fee; (ii) such loss of talent negatively impacted the quality of the Company’s investment portfolio; and (iii) as a result, Capitala’s public statements were materially false and misleading at all relevant times.
On August 7, 2017, the Company revealed during aftermarket hours that six of its investments were on non-accrual status—twice as many as in the previous quarter.
On August 8, 2017, the Company’s Chief Executive Officer Joseph B. Alala III revealed that Capitala Investment Advisors had been losing professional talent in underwriting and portfolio management since waiving its incentive fee, which resulted in a rising number of nonaccrual investments.
On this news, shares of the Company fell $3.82 per share, or approximately 30%, over the next three trading days to close at $8.99 per share on August 10, 2017, damaging investors.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com
CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]


Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Anta Sports Expands Global Footprint With Strategic Puma Stake 



